We are live on
!
Find out more
AC
Athanor Capital Portfolio holdings
AUM
$24.6M
1-Year Est. Return
2.49%
This Fund
S&P 500
This Quarter
Est. Return
-0.77%
1 Year Est. Return
+2.49%
3 Year Est. Return
+171.12%
5 Year Est. Return
+304.82%
10 Year Est. Return
–
AUM
$1.55B
AUM Growth
+$774M
(+99%)
Cap. Flow
+$915M
Cap. Flow
% of AUM
58.83%
Top 10 Holdings %
Top 10 Hldgs %
44.46%
Holding
252
New
111
Increased
67
Reduced
24
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$51.4M |
| 2 |
Amazon
AMZN
|
+$34.5M |
| 3 |
AGN
Allergan plc
AGN
|
+$31.2M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$23.6M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$31M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$26.5M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$11.5M |
| 4 |
DATA
Tableau Software, Inc.
DATA
|
+$10.2M |
| 5 |
LyondellBasell Industries
LYB
|
+$8.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.16% |
| 2 | Consumer Discretionary | 10.06% |
| 3 | Communication Services | 7.91% |
| 4 | Financials | 7.41% |
| 5 | Healthcare | 6.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Broadcom
AVGO
$1.85T
| $939K | 0.06% |
+34,000
| New | +$967K |
|
|
ZGNX
127
DELISTED
Zogenix, Inc.
ZGNX
| $912K | 0.06% |
22,765
+16,065
| +240% | +$740K |
|
|
TPTX
128
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $895K | 0.06% |
23,800
+10,600
| +80% | +$461K |
|
|
MSGN
129
DELISTED
MSG Networks Inc.
MSGN
| $811K | 0.05% |
+50,000
| New | +$894K |
|
|
MSGN
130
PUT
DELISTED
MSG Networks Inc.
MSGN
| $811K | 0.05% |
+50,000
| New | +$894K |
|
|
GBT
131
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $805K | 0.05% |
+16,600
| New | +$865K |
|
132
BridgeBio Pharma
BBIO
$15.7B
| $793K | 0.05% |
+36,948
| New | +$1.02M |
|
133
Adaptive Biotechnologies
ADPT
$3.59B
| $708K | 0.05% |
+22,900
| New | +$935K |
|
134
Cytokinetics
CYTK
$10.5B
| $700K | 0.05% |
61,500
+40,000
| +186% | +$502K |
|
135
Wave Life Sciences
WVE
$1.09B
| $690K | 0.04% |
33,600
+11,900
| +55% | +$273K |
|
|
THOR
136
DELISTED
Synthorx, Inc. Common Stock
THOR
| $680K | 0.04% |
41,800
+20,342
| +95% | +$340K |
|
137
Las Vegas Sands
LVS
$31.7B
| $676K | 0.04% |
11,700
+3,300
| +39% | +$192K |
|
138
Alexandria Real Estate Equities
ARE
$8.97B
| $665K | 0.04% |
+4,315
| New | +$638K |
|
139
CALL
Coherent
COHR
$51.4B
| $662K | 0.04% |
+18,800
| New | +$717K |
|
|
ATVI
140
DELISTED
Activision Blizzard
ATVI
| $662K | 0.04% |
12,500
-600
| -5% | -$29.9K |
|
141
Appian
APPN
$1.98B
| $603K | 0.04% |
+12,705
| New | +$595K |
|
|
APLS
142
DELISTED
Apellis Pharmaceuticals
APLS
| $590K | 0.04% |
24,500
+9,300
| +61% | +$256K |
|
|
BHVN
143
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $580K | 0.04% |
13,900
+9,200
| +196% | +$389K |
|
|
SFIX
144
PUT
Stitch Fix
SFIX
$536M
| $578K | 0.04% |
+30,000
| New | +$697K |
|
145
Iovance Biotherapeutics
IOVA
$1.82B
| $571K | 0.04% |
+31,400
| New | +$694K |
|
146
Zillow
Z
$7.79B
| $566K | 0.04% |
19,000
-53,700
| -74% | -$2.14M |
|
|
RARX
147
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $544K | 0.04% |
23,000
+9,400
| +69% | +$279K |
|
148
AC Immune
ACIU
$223M
| $537K | 0.03% |
108,540
+66,440
| +158% | +$356K |
|
149
Marvell Technology
MRVL
$168B
| $529K | 0.03% |
+21,200
| New | +$532K |
|
150
Incyte
INCY
$24.2B
| $520K | 0.03% |
+7,000
| New | +$566K |
|
Similar funds
EGA
VH
JM
OA
HSCM
CCA
ECM
RCGV
Athanor Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Athanor Capital held 252 positions worth $1.55B, up 99% from $780M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Athanor Capital deployed $915M of net new capital in Q3 2019, opening 111 new positions and adding to 67 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 162,500 shares worth $19.4M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was VanEck JP Morgan EM Local Currency Bond ETF, an estimated $7.59M trimmed.
- Athanor Capital's largest Q3 2019 buy was iShares MSCI USA Momentum Factor ETF: 162,500 shares worth $19.4M.
- Athanor Capital added most to Altaba Inc in Q3 2019, an estimated $51.4M increase.
- Athanor Capital's biggest Q3 2019 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $7.59M.
- Athanor Capital fully exited Anadarko Petroleum in Q3 2019, selling an estimated $31M.
- Athanor Capital's ten largest holdings make up 44% of its $1.55B portfolio in Q3 2019.
- Athanor Capital opened 111 new positions and closed 48 in Q3 2019.
- Athanor Capital's portfolio value rose 99% quarter-over-quarter to $1.55B.
Based on Athanor Capital's 13F filing for Q3 2019, filed 14 Nov 2019.